Literature DB >> 32934064

Optimising the management of osteoporosis.

Ziad Farrah1, Ali Sm Jawad2.   

Abstract

With increasing longevity of the population globally, the prevalence of osteoporosis will rise, associated with significant morbidity, disability and increased mortality. Adequate intake of calcium, vitamin D, increasing physical activity, a strategy of avoiding falls, cessation of smoking and avoiding excessive alcohol intake are pivotal in maintaining healthy bones in all age groups. Oral bisphosphonates remain the most cost-effective first line of treatment. Better methods of identifying patients with high fracture risk is needed as there is adequate effective treatment for osteoporosis. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Osteoporosis; bisphosphonates; denosumab; teriparatide

Mesh:

Substances:

Year:  2020        PMID: 32934064      PMCID: PMC7539745          DOI: 10.7861/clinmed.2020-0131

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  55 in total

Review 1.  Osteoporosis.

Authors:  J E Compston
Journal:  Clin Endocrinol (Oxf)       Date:  1990-11       Impact factor: 3.478

2.  Fracture risk following intermission of osteoporosis therapy.

Authors:  E M Dennison; C Cooper; J A Kanis; O Bruyère; S Silverman; E McCloskey; B Abrahamsen; D Prieto-Alhambra; S Ferrari
Journal:  Osteoporos Int       Date:  2019-06-07       Impact factor: 4.507

Review 3.  Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials.

Authors:  Ana Boquete-Castro; Gerardo Gómez-Moreno; José Luis Calvo-Guirado; Antonio Aguilar-Salvatierra; Rafael Arcesio Delgado-Ruiz
Journal:  Clin Oral Implants Res       Date:  2015-02-02       Impact factor: 5.977

4.  Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.

Authors:  Richard Prince; Adrien Sipos; Anwar Hossain; Unni Syversen; Sophia Ish-Shalom; Ewa Marcinowska; Johan Halse; Robert Lindsay; Gail P Dalsky; Bruce H Mitlak
Journal:  J Bone Miner Res       Date:  2005-05-02       Impact factor: 6.741

5.  Classification of osteoporosis in the elderly is dependent on site-specific analysis.

Authors:  S L Greenspan; L Maitland-Ramsey; E Myers
Journal:  Calcif Tissue Int       Date:  1996-06       Impact factor: 4.333

6.  Bone-density testing interval and transition to osteoporosis in older women.

Authors:  Margaret L Gourlay; Jason P Fine; John S Preisser; Ryan C May; Chenxi Li; Li-Yung Lui; David F Ransohoff; Jane A Cauley; Kristine E Ensrud
Journal:  N Engl J Med       Date:  2012-01-19       Impact factor: 91.245

Review 7.  Vertebral fracture assessment: Enhancing the diagnosis, prevention, and treatment of osteoporosis.

Authors:  Meltem Zeytinoglu; Rajesh K Jain; Tamara J Vokes
Journal:  Bone       Date:  2017-03-08       Impact factor: 4.398

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

Review 9.  Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Authors:  E Hernlund; A Svedbom; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

Review 10.  Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

Authors:  H A Bischoff-Ferrari; B Dawson-Hughes; H B Staehelin; J E Orav; A E Stuck; R Theiler; J B Wong; A Egli; D P Kiel; J Henschkowski
Journal:  BMJ       Date:  2009-10-01
View more
  6 in total

1.  Relationship between blood manganese and bone mineral density and bone mineral content in adults: A population-based cross-sectional study.

Authors:  Chao Wang; Yong Zhu; Haitao Long; Mingning Ou; Shushan Zhao
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

2.  Association between Serum Testosterone Levels and Body Composition among Men 20-59 Years of Age.

Authors:  Jiajie Ye; Xiaojun Zhai; Jinxiao Yang; Zhongxin Zhu
Journal:  Int J Endocrinol       Date:  2021-09-20       Impact factor: 3.257

3.  Network Pharmacology-Based Strategy and Molecular Docking to Explore the Potential Mechanism of Jintiange Capsule for Treating Osteoporosis.

Authors:  Zhao Yang; Zhen-Zhen Yuan; Xin-Long Ma
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-03       Impact factor: 2.629

4.  Can waist circumference be a predictor of bone mineral density independent of BMI in middle-aged adults?

Authors:  Ying Hua; Jinqiong Fang; Xiaocong Yao; Zhongxin Zhu
Journal:  Endocr Connect       Date:  2021-10-13       Impact factor: 3.335

Review 5.  The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis.

Authors:  Maurizio Muraca; Alfredo Cappariello
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

6.  Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.

Authors:  U Stumpf; M Kraus; P Hadji
Journal:  Osteoporos Int       Date:  2021-05-26       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.